Our results showed that the levels of heparinase 1, MMP9, β-catenin, and N-cadherin were significantly downregulated in ovarian cancer cells in response to Gleditsiae Spina treatment in a dose-dependent manner. This evidence concerns the gene CDH2 and ovarian carcinoma.